Clinical trial

ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population

NCT06790355

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-03-01

PhaseNA

Study timeline

Study start (actual)2025-03-01Date precision: day

Registry last updated2026-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerverified · MONDO: lung cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Liver Cancerverified · MONDO: liver cancer

Grastic Cancerunresolved

Esophageal Cancerverified · MONDO: esophageal cancer

Interventions

multi-cancer early detectionDEVICE

Sponsors & collaborators

Shanghai Weihe Medical Laboratory Co., Ltd.lead sponsor

Fudan Universitycollaborator

Mapped research locations

ShanghaiShanghai Municipality, China1 NanjingJiangsu, China1 ZhengzhouHenan, China1 FuzhouFujian, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06790355 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.